L&C Bio has set the final issue price for its paid-in capital increase at KRW 39,100 per share.

L&C Bio has set the final issue price for its paid-in capital increase at KRW 39,100 per share. This is the lower of the 1st and 2nd issue prices. According to the company, in determining the issue price it applied a 40% discount to the weighted arithmetic average stock price over the past 3 to 5 trading days. The number of shares to be issued is 3.7 million, and the same price will apply to the public offering.

1. 01

   The company will issue 3.7 million registered common shares at KRW 39,100 per share.

2. 02

   The final issue price was determined as the lower of the 1st issue price (KRW 39,100) and the 2nd issue price (KRW 42,400).

3. 03

   In determining the issue price, the company applied a 40% discount to the weighted arithmetic average stock price over the past 3 to 5 trading days.

4. 04

   The public offering issue price will also apply the same price (KRW 39,100) that was applied to existing shareholders' subscription.

An AI model translated the Korean summary of this filing into English; every number is carried over from the Korean original. Reference information, not investment advice.

Key figures

Number of shares issued

3,700,000 shares

Final issue price (per share)

KRW 39,100

1st issue price

KRW 39,100

2nd issue price

KRW 42,400

Par value

KRW 500

Confirmation date

October 8, 2026

Filing facts

Filing type

Rights Offering

Report name

Final Issue Price of Rights Offering

Filed

Oct 12, 2026

Receipt number

20261012900305